Fortress Biotech R&D Summit
Day One: Tuesday, April 5, 2022 (1:00 p.m. – 3:00 p.m. ET)
1:00 p.m. ET - Opening Remarks and Fortress Strategy
Lindsay Rosenwald, M.D., Chairman, President & Chief Executive Officer of Fortress Biotech; Mayank Mamtani, Head of HC Research, B. Riley Securities
1:30 p.m. ET - Panel #1 – Journey Medical Corporation (NASDAQ: DERM)
Claude Maraoui, Co-Founder, President & Chief Executive Officer; Ernie De Paolantonio, Chief Financial Officer; Ramsey Alloush, General Counsel
2:00 p.m. ET - Panel #2 – Cyprium Therapeutics
Charles Buchen, M.D., Chief Business Officer; Lung Yam, M.D., Ph.D., President & Chief Scientific Officer
2:30 p.m. ET - Panel #3 – UR-1 Therapeutics
Raymond Zheng, Ph.D., President & Chief Scientific Officer; Scott Baumgartner, M.D., Interim Chief Medical Officer
Day Two: Wednesday, April 6, 2022 (1:00 p.m. – 3:00 p.m. ET)
1:00 p.m. ET – Fortress Strategy – Execution and Value Generation
Lindsay Rosenwald, M.D., Chairman, President & Chief Executive Officer of Fortress Biotech
1:30 p.m. ET - Panel #1 – Mustang Bio (NASDAQ: MBIO)
Manuel Litchman, M.D., President & Chief Executive Officer; Knut Niss, Ph.D., Chief Technology Officer; Bruce Dezube, M.D., Senior Vice President, Head of Clinical Development; Eliot Lurier, C.P.A., Interim Chief Financial Officer
2:15 p.m. ET - Panel #2 – Checkpoint Therapeutics (NASDAQ: CKPT)
James F. Oliviero, President & Chief Executive Officer; Garrett Gray, Chief Financial Officer